Page last updated: 2024-10-20

pyrazinamide and Leprosy, Borderline

pyrazinamide has been researched along with Leprosy, Borderline in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levy, L1

Other Studies

1 other study available for pyrazinamide and Leprosy, Borderline

ArticleYear
Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1988, Volume: 56, Issue:4

    Topics: Animals; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Mice; Pyrazin

1988